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Background: Fatigue is common in stroke survivors. Lesion location may influence the risk of poststroke fatigue
(PSF) but it is uncertain whether location has an impact on the prognosis of PSF. This study examined the
association between PSF outcome and infarct location.
Methods: The study sample comprised 435 Chinese patients with acute ischemic stroke admitted to the acute
stroke unit of a university affiliated regional hospital in Hong Kong. Three and fifteen months after the onset of the
index stroke a research assistant administered the Fatigue Severity Scale (FSS). PSF was defined as a FSS score of 4.0
or above. Of the 139 patients with PSF three months poststroke, 97 (69.8%) attended the 15-month follow-up, when
50 (51.5%) patients still had PSF (‘non-remitters’) and 47 (48.5%) did not report fatigue (‘remitters’). The presence
and location of infarcts were evaluated with magnetic resonance imaging.
Results: In comparison with the remitters, the non-remitters were more likely to have subcortical white matter
infarcts (40.0% vs 21.3%, p = 0.046). These infarcts remained an independent predictor of non-remission of PSF
in the multivariate analysis, with an odds ratio of 4.208 (p = 0.011).
Conclusions: The results suggest that subcortical white matter infarcts may influence the outcome of PSF.
Further investigations are needed to explore whether infarcts have any impact on the response of PSF to
pharmacological or psychological interventions.
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Fatigue is very common following stroke, with a reported
frequency of 35% to 92% [1]. One year after the index
stroke, the frequency of poststroke fatigue (PSF) varies
from 18% to 36% [2-4]. Only a few studies have examined
the possible clinical predictors of non-remission of PSF.
Snaphaan et al. [5] followed up 108 stroke survivors for
1.5 years and found no significant differences between
patients with PSF and patients who recovered. Factors
associated with PSF 1 year poststroke (incident or
persistent) include younger [3] or older age, [2] female
sex [2], more severe stroke [6], poor functional status* Correspondence: tangwk@cuhk.edu.hk
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unless otherwise stated.[7], fatigue severity at baseline [3], insomnia [6] and
depressive symptoms [2-4,6].
The impact of lesion location on PSF at the chronic stage
of stroke remains controversial. The abovementioned follow-
up study [5] found no association between PSF at 1.5 years
poststroke and lesion location (cortical vs subcortical
or subcortical white matter vs basal ganglia vs thalamus)
or white matter hyperintensities. No association was re-
ported between stroke type [2,6], laterality [2,8] and site
[4] and PSF at 1 year poststroke. None of these studies
compared remitted and non-remitted PSF patients at
follow up, or thoroughly evaluated lesion location [2,6,8]
or used validated measures of PSF [6].
It has been suggested that structures involved in the
subcortical attentional network play a critical role in the
pathophysiology of PSF [3,9]. Several studies reported
associations between lesion location and PSF with rightd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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capsule and basal ganglia strokes [12], although there
were negative reports [13,14]. If infarct locations affect
the risk of PSF, then it is possible that they also influence
its outcome.
As no data have been published on the brain imaging
predictors of outcome in PSF, the aim of this study was
to determine the relationship between infarct location
and the course of PSF.
Methods
Patients
All included patients attended the 3- and 15-month follow
ups in person. A total of 4,048 patients with first-ever or
recurrent acute ischemic stroke were admitted to the
Acute Stroke Unit of the Prince of Wales Hospital
between May 2007 and March 2011. Prince of Wales is a
university-affiliated general hospital serving a population
of 800,000 in Hong Kong. Of the 4,048 patients, 1,534
received an MRI examination; 710 patients did not attend
the 3-month follow-up because they could not be con-
tacted (n = 328), refused to participate (n = 227), were phys-
ically frail (n = 109) or were deceased (n = 46). The study
sample comprised 435 (28.4%) patients who fulfilled the
entry criteria listed below. Excluded patients (n = 1099)
were older (67.7 ± 12.4 vs 65.9 ± 9.9, p =0.008) and had
a higher National Institutes of Health Stroke Scale (NIHSS)
[15] scores (5.2 ± 5.3 vs 3.7 ± 3.2, p < 0.001) but the sex
distribution of the two groups was close to even (44.5% vs
41.1% female, p = 0.233).
The inclusion criteria for the study were 1. Chinese
ethnicity; 2. Cantonese as the primary language; 3. age of
18 or above; 4. well-documented (clinical presentation
and CT scan of the brain) first or recurrent acute stroke
occurring up to 7 days before admission; and 5. ability
and willingness to give consent. The exclusion criteria
included 1. transient ischemic attack, cerebral haemor-
rhage, subdural haematoma or subarachnoid haemor-
rhage; 2. another stroke before the 3-month follow up; 3.
history of a CNS disease such as tumour, Parkinson’s
disease, etc.; 4. history of depression or substance abuse/
dependence or other psychiatric disorder before the
index stroke; 5. moderate or severe dementia defined as
a Mini-Mental State Examination (MMSE) [16] score
less than 20; and 6. severe aphasia and hearing or visual
impairment.
Of the 435 patients screened, 139 reported PSF at the
3-month follow-up (baseline). One-year after the baseline
assessment (i.e., 15 months after the index stroke), 97
(69.8%) of these 139 patients attended the follow-up assess-
ment. Patients who did not attend the follow-up (n = 42)
were older (68.3 ± 9.2 vs 63.5 ± 10.0, p = 0.008) than those
who attended the follow-up. The sex distribution (40.5% vs
52.6% female, p = 0.190), mean age (65.7 ± 11.0 vs 67.2 ±10.5; p = 0.319), and mean NIHSS (3.9 ± 3.4 vs 3.9 ± 2.9,
p = 0.978) score of the two groups were similar. The
study protocol was approved by the Clinical Research
Ethics Committee of the Chinese University of Hong
Kong. All participants signed a consent form.
Collection of demographic and clinical data
A research nurse collected the demographic data (age,
sex and years of education), history of hypertension, diabetes
mellitus, hyperlipidemia and previous stroke, and assessed
the stroke severity using the NIHSS [17] on admission.
At the 15-month follow-up, recurrence of stroke was
also recorded.
Assessment of PSF
Three and 15 months after the onset of the index stroke, a
trained research assistant who was blind to the patients’
radiological data administered the Chinese version of the
Fatigue Severity Scale (FSS) [18,19]. PSF was defined as an
FSS score of 4.0 or more. Patients who had PSF at the
3- but not 15-month follow-up constituted the ‘remit-
ters’ group.
Three months after the index stroke, global cognitive
functions were evaluated with the Cantonese version of
the MMSE [16]. Insomnia was assessed by the following
question: ‘How many days of insomnia per week do you
think you have? [20,21]’. Patients were identified as hav-
ing insomnia if they scored more than 0 days. Depressive
symptoms were measured with the locally validated
Geriatric Depression Scale (GDS) [22]. The Barthel Index
(BI) [23] was used to assess the extent of patients’
disability in daily functions. Patients were also asked if
they experienced pain in the last month with the following
question: ‘Do you consider yourself as having pain?’
Radiological examination
MRI was performed with a 1.5-T system (Sonata, Sie-
mens Medical, Erlangen, Germany) within 7 days of ad-
mission. The following sequences were acquired: diffusion
weighted imaging (DWI) (TR/TE/excitation = 180/122/4,
matrix = 128 × 128, FOV= 230 mm, slice thickness/gap =
5 mm/1 mm, echo planar imaging, single shot factor = 90)
with three orthogonally applied diffusion gradients (b values
of 1000 500, and 0 s/mm2); and axial spin echo (SE)
T1-weighted FFE sequence (TR/TE/excitation = 25/2.3/1,
flip angle 30° FOV = 230 mm, slice thickness/gap =
3 mm/-1.5 mm, matrix = 256 × 256), turbo spin echo (TSE)
T2–weighted (TR/TE/excitation = 2622/80/2, turbo factor
of 18, FOV = 230 mm, slice thickness/gap = 5 mm/
0.5 mm, matrix = 512 × 346); axial Flair (fluid attenuated in-
version recovery) sequence (TR/TE/TI/excitation = 11000/
125/2800/1, turbo factor of 31, FOV= 230 mm, slice thick-
ness/gap= 5 mm/0.5 mm, matrix = 352 × 248) and blood sen-
sitive gradient echo sequence (TR/TE/excitation = 350/30/2,
Table 1 Demographic and clinical characteristics of
non-remitters and remitters of poststroke fatigue
Non-remitters Remitters
N = 50 N = 47
Mean ± SD Mean ± SD p
Age 62.7 ± 9.9 64.4 ± 10.1 0.421a
Female 30 (60.0) 21 (44.7) 0.131b
Education (years) 5.6 ± 4.1 6.4 ± 4.8 0.389a
Hypertension 36 (72.0) 32 (68.1) 0.674b
Diabetes mellitus 19 (38.0) 11 (23.4) 0.120b
Hyperlipidemia 30 (60) 24 (55.1) 0.376b
Previous stroke 8 (16.0) 4 (8.5) 0.263b
NIHSS total score 4.1 ± 2.2 3.7 ± 3.5 0.464a
Barthel index 19.1 ± 2.4 19.0 ± 2.7 0.783a
Mini-mental state examination
score
27.0 ± 2.4 27.8 ± 2.6 0.134a
Geriatric depression scale score 7.6 ± 4.4 4.9 ± 3.9 0.002a
Fatigue severity scale score 5.1 ± 0.6 5.0 ± 1.1 0.564a
Presence of pain 31 (63.3) 13 (27.7) 0.001b
Presence of insomnia 39 (79.6) 26 (55.3) 0.011b
Recurrent stroke 2 (4.0) 1 (2.1) 1.000C
NIHSS indicates National Institutes of Health Stroke Scale.
at test; bChi-square test; CFisher’s exact test.
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0.5 mm, FOV = 230 mm, matrix = 256 × 256).
A neurologist (YKC) who was blind to the psychiatric
diagnoses and clinical data other than age and sex assessed
the MRIs for the following.
(1) Infarcts; the total area of acute infarcts on DWI
was measured using manual outlines. Acute infarcts
were defined as areas of restricted water diffusion
identified on DWI with b values of 1000 together
with hypointensity on the corresponding ADC map.
Acute infarcts were divided into cortical (frontal,
temporal, parietal and occipital), subcortical
(subcortical white matter, basal ganglia and
thalamus) and infratentorial (brainstem and
cerebellum). If an infarct involved both subcortical
white and grey matter, it was counted as both a
subcortical white matter infarct and a grey matter
infarct. The total volume was calculated by
multiplying the total area by the sum of the slice
thickness and the gap. The number of old infarcts was
also recorded. Chronic infarcts were defined as focal
hyperintensities on T2-weighted and hypointensities
on T1-weighted images with size ≥3 mm. Lesions less
than 3 mm were considered as dilated perivascular
space. Intra-rater reliability tests were performed on
20 patients; the kappa values for the volume and
number of infarcts were 0.96 and 0.94, respectively.
(2) The severity of WMHs was graded using the
Fazekas scale at the periventricular and deep white
matter regions, respectively, with a scale ranging
from 0, 1, 2, to 3 [24].
Statistical analysis
All statistical tests were performed using SPSS for Windows
(Release 20.0; SPSS Inc., Chicago, IL). The demographic and
clinical variables and radiological characteristics of the re-
mitters were compared with those of the non-remitters
using Fisher’s exact test and Student’s t-test, as appropriate.
Risk factors with values of p < 0.10 were then analysed with
multivariate logistic regression analysis employing a forward
stepwise selection strategy. If the correlations between any
of these putative risk factors were >/=0.50, then additional
models were examined to rule out co-linearity. In the
analysis, the odds ratio of any independent risk factor was
interpreted as the risk of non-remission of PSD when all
other risk factors were held constant. The level of signifi-
cance was set at 0.05.
Results
The final sample (n = 97) had the following characteristics:
51 patients (55.6%) were women, and 12 (12.4%), 60 (70.1%),
30 (30.9%), 54 (55.7%) had histories of stroke, hypertension,
diabetes mellitus and hyperlipidemia, respectively. The meanage and education (in years) were 65.0 ± 10.0 and 6.0 ± 4.9,
respectively. The mean NIHSS score on admission was
3.9 ± 3.1. The BI, MMSE, GDS and FSS scores at base-
line were 19.1 ± 2.4, 27.2 ± 2.6, 6.4 ± 4.4, and 5.0 ± 0.8,
respectively. Forty-four (45.4%) patients experienced pain
and 65 (67.0%) reported insomnia. Three (3.1%) patients
had another stroke before the 15-month follow-up.
Of the 97 patients who attended the 15-month follow-
up, 50 (51.5%) still had PSF (non-remitters) and 47
(48.5%) did not (remitters). Compared with the remitters,
the non-remitters had higher baseline GDS scores (p =
0.002), were more likely to report pain (p = 0.001) and expe-
rienced more insomnia (Table 1). The non-remitters were
more likely to have subcortical white matter infarcts (40.0%
vs 21.3%, p = 0.046) (Table 2). There was no significant
association between baseline FSS score and the pres-
ence of subcortical white matter infarcts (Spearman’s
rho = −0.061, p = 0.504). The medians of the difference
between baseline and follow-up FSS scores in patients
with and without subcortical white matter infarcts were 0
and −1, respectively (Mann–Whitney U test, p < 0.001).
The presence of subcortical white matter infarcts, pain,
insomnia, age, sex, GDS and NIHSS score were entered in
the regression model. The presence of subcortical white
matter infarcts was a significant predictor of non-remission
of PSD with an odds ratio of 4.208 (p = 0.011). Other
predictors included pain and GDS score (Table 3).
Table 2 Radiological characteristics of non-remitters and
remitters of poststroke fatigue
Variable Non-remitters Remitters
N = 50 N = 47
Mean ± SD Mean ± SD p
Number of acute infarcts 2.1 ± 2.9 1.1 ± 1.2 0.131C
Volume of acute infarct (cm3) 1.6 ± 2.1 3.1 ± 5.3 0.777C
Cortical 10 (20.0) 10 (21.3) 0.877b
Frontal 9 (18.0%) 4 (8.5%) 0.170a
Temporal 1 (2.0%) 1 (2.1%) 1.000b
Parietal 3 (6.0%) 2 (4.3%) 1.000b
Occipital 0 (0%) 2 (4.3%) 0.232b
Subcortical white matter 20 (40.0%) 10 (21.3%) 0.046a
Basal ganglia 8 (16.0%) 9 (19.1%) 0.684a
Thalamus 4 (8.0%) 3 (6.4%) 1.000b
Infratentorial 4 (8.0%) 9 (19.1%) 0.107b
Brain stem 4 (8.0%) 6 (12.8%) 0.516b
Cerebellum 1 (2.0%) 4 (8.5%) 0.195b
Fazekas DWMH score 1.1 ± 0.9 1.2 ± 0.8 0.549C
Fazekas PVH score 1.2 ± 0.8 1.3 ± 0.7 0.637C
Number of old infarcts 0.5 ± 1.1 0.7 ± 1.5 0.370C
DWMH indicates deep white matter hyperintensities; PVH,
Periventricular hyperintensities.
aChi-square test; bFisher’s exact test; CMann-Whitney U test.
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To the best of our knowledge, this is the first report of
an association between the location of acute infarcts and
PSF outcome. The main finding is that subcortical white
matter infarcts are associated with persistent fatigue
15 months after the index stroke in patients with well-
established stroke.
A few studies have evaluated the possible impact of
lesion location on PSF at the chronic stage of stroke,
with negative results. Schepers et al. [25] did not findTable 3 Multivariate logistic model of the clinical
determinants of non-remission of poststroke fatigue
Parameter Adjusted odds ratio (95% C.I.) p
Subcortical white matter infarct 4.208 (1.396 -12.681) 0.011
Presence of pain 5.664 (2.102 - 15.268) 0.001
Geriatric depression scale score 1.218 (1.072 - 1.383) 0.002





The presence of subcortical white matter infarcts, pain, insomnia, Geriatric
Depression Scale score, age, sex and National Institute of Health Stroke Scale
score were entered in the regression model.any association between laterality or type of stroke (is-
chemic vs haemorrhagic) and PSF at 1 year poststroke in
167 stroke patients [2]. Another study on 253 patients
also found that stroke type was not related PSF at 1 year
poststroke [6]. No association was found between PSF at
1.5 years poststroke and lesion location or white matter
hyperintensities [3], and no relationship was found between
lesion site and PSF 1 year poststroke in 99 stroke survivors
[4]. Type or laterality of stroke was not related to increased
fatigue in 242 patients at 6 months poststroke [8].
The importance of white matter lesions in the pathophysi-
ology of fatigue has been reported in non-stroke patient
populations. Reduced white matter volume was observed in
chronic fatigue syndrome [26]. Increased white matter
hyperintensities were also found to be associated with in-
creased fatigue in systemic lupus erythematosus [27]. White
matter micro-structural damage was correlated with fatigue
severity in multiple sclerosis [28]. Our previous MRI study
demonstrated that internal capsule infarcts were more com-
mon in PSF [12]. Alterations of the integrity of white matter
were related to the outcome of late-life depression [29,30]. It
is possible that by disrupting the subcortical attentional net-
work subcortical white matter infarcts adversely affect the
outcome of PSF in stroke.
The remission rate of PSF in this study is higher than
the figures of 18-36% reported in the literature [2-4,7,8].
Ten of the 38 patients with PSF at baseline had recov-
ered by the 1.5-year follow-up, yielding a remission rate
of 26.3%; no predictor of remission could be found [5].
In another study, 10 of 86 patients with PSF at baseline
recovered by follow-up, yielding a remission rate of
19.8%; again, remission could not be predicted [2]. The
remission rate of PSF between 6–12 and 24 months
poststroke was 22.7% [31] and 35.6% [7], respectively. A
6-month follow-up of 242 patients reported that 17.8%
had significant reductions in fatigue [8]. Patients with a
history of depression were excluded from our study,
which may have reduced the proportion of patients with
persistent fatigue because depressive symptoms were
one of the predictors of non remission. Depressive
symptoms also predicted PSF at follow up [2-4,32].
In this study, depression severity and the presence of
pain and insomnia predicted the persistence of PSF. Pain
and sleep disturbances have been found to be associated
with PSF at baseline [33] and one-year follow up [6].
Depressive symptoms at baseline also predicted PSF at 1
to 1.5 year follow ups [5,25,31,34]. There is a symptom-
atic overlap between PSF and poststroke depression [35].
Fatigue can be a symptom [36] as well as a risk factor of
PSD [37]. Fatigue can also occur in the absence of
depression: only 28-38% of stroke patients with severe fa-
tigue have depression [13,38]. Factor analysis has revealed
that PSF and PSD can be separated into two distinct
constructs [39]. Impairment of locomotion, rather than
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of fatigue in one study of stroke patients [38].
Antidepressant treatment usually improves depression
but not fatigue in patients with PSF [40]. Hence, PSF
and poststroke depression should be treated as two
distinct, albeit partially overlapping conditions.
Limitations
The main limitation of this study is its relatively high
loss of patients to follow-up (the ideal sample size would
have been 653 if there had been no attrition) and its
small sample size, which reduced its statistical power.
Stroke severity in the final study sample was mild and
patients who could not give consent due to dementia or
aphasia were excluded. This selection bias may limit the
generalizability of the findings to patients with more
severe stroke.
Conclusions
In conclusion, the findings indicate that subcortical white
matter infarcts are associated with a higher risk of non-
remission of PSF. Further investigations are needed to
clarify whether infarcts have any impact on the response of
PSF to pharmacological and psychological interventions.
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